| AMGEN INC. DL-,0001 | 161.72 / -0.82% |
| Date/Time | 06/25 / 12:02 |
| Chg. / Chg.(%) | -1.34 / -0.82% |
| Bid | 161.54 / 290 |
| Ask | 162.52 / 316 |
| Open | 162.00 |
| Previous Close | 163.06 |
| High | 162.00 |
| Low | 161.72 |
| Volume [EUR] | 9,228.68 |
| Volume [Units] | 57 |
| Price fixings | 3 |
| ISIN | US0311621009 |
| Security | AMG |
| Exchange | Xetra |
| Type | Stock |
| Exchange | Last | Volume | |
|---|---|---|---|
| TradeGate | 161.380 |  |
145 |
| Xetra | 161.72 | |
57 |
| Stuttgart | 161.100 |  |
32 |
| Frankfurt | 162.160 | |
30 |
| Vienna Globa.. | 163.30 | |
0 |
| Düsseldorf | 161.20 | |
0 |
| Berlin | 161.32 | |
0 |
| München | 162.22 | |
0 |
| Hannover | 161.22 | |
0 |
| Hamburg | 161.22 | |
0 |
| Lang & Schwa.. | 161.633 | |
|
| gettex | 162.060 | |
|
| NASDAQ | 184.8300 | |
2,948,402 |
| Cboe US | 184.86 | 145,815 | |
| IEX | 184.81 | |
76,504 |
| London Inter.. | 186.58 | 1,744 | |
| Borsa Italia.. | 165.00 | 12 | |
| Mexico | 3,540.07 | 472 | |
| SIX Swiss Ex.. | 181.71 | ||
| SIX Swiss Ex.. | 179.32 | ||
| Borsa Italia.. | 165.00 |
News
- Keytruda (pembrolizumab; Merck & Co) Analyst Outlook 2019
12:09 - GlobeNewswire - Cytokinetics Announces Preclinical Data for Reldesemtiv to be Presented at the 2019 Annual Cure SMA Conference
06/24/2019 / 22:00 - GlobeNewswire - Global Biosimilars Market Analysis, Trends and Forecasts Through 2015-2022
06/24/2019 / 12:29 - GlobeNewswire - Global $24.2 Bn Plaque Psoriasis Drug Forecast and Market to 2027: Amgen's Enbrel, Janssen's Remicade and AbbVie's Humira Dominated the Market for Over 10 Years
06/21/2019 / 15:42 - GlobeNewswire - Contraceptive Pills: Insights Into & Future of the Market (2019-2024) - Generic Oral Contraceptive is Expected to Hold the Largest Share
06/21/2019 / 14:07 - GlobeNewswire
Real-time